BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-3.41%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$800M
AUM Growth
+$800M
(-11%)
Cap. Flow
-$30M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
66.9%
Holding
36
New
3
Increased
1
Reduced
4
Closed
2
Top Buys
| 1 |
Disc Medicine
IRON
|
$42.2M |
| 2 |
Aclaris Therapeutics
ACRS
|
$27.5M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$21.8M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$3.89M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$45M |
| 2 |
Natera
NTRA
|
$38.9M |
| 3 |
Protagonist Therapeutics
PTGX
|
$25.8M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$11.2M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$2.41M |
Sector Composition
| 1 | Healthcare | 98.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$2.71B
| $110M | 13.76% | 8,300,000 | – | – |
|
2
Nuvalent
NUVL
$5.52B
| $93.3M | 11.66% | 3,577,267 | – | – |
|
|
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
| $79.3M | 9.91% | 3,081,307 -1,750,000 | -36% | -$45M |
|
|
4
Disc Medicine
IRON
$2.07B
| $42.2M | 5.27% | +1,990,914 | New | +$42.2M |
|
|
5
Natera
NTRA
$23.1B
| $38.9M | 4.86% | 700,197 -699,803 | -50% | -$38.9M |
|
6
Dynavax Technologies
DVAX
$1.19B
| $38.4M | 4.8% | 3,915,000 | – | – |
|
7
Crinetics Pharmaceuticals
CRNX
$2.92B
| $37M | 4.63% | 2,305,558 | – | – |
|
8
Mersana Therapeutics
MRSN
$36.5M
| $35.6M | 4.45% | 8,663,673 | – | – |
|
9
Arcutis Biotherapeutics
ARQT
$1.86B
| $33M | 4.12% | 3,000,000 | – | – |
|
|
10
Aclaris Therapeutics
ACRS
$209M
| $27.5M | 3.44% | +3,400,000 | New | +$27.5M |
|
11
Pharvaris
PHVS
$1.39B
| $25.6M | 3.2% | 3,180,601 | – | – |
|
12
Savara
SVRA
$567M
| $22.7M | 2.83% | 11,622,598 | – | – |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $21.8M | 2.72% | +2,500,000 | New | +$21.8M |
|
|
CTIC
14
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $19.8M | 2.47% | 4,702,996 +925,688 | +25% | +$3.89M |
|
|
EQRX
15
DELISTED
EQRx, Inc. Common Stock
EQRX
| $19.4M | 2.43% | 10,003,573 | – | – |
|
16
Annexon
ANNX
$226M
| $18.8M | 2.35% | 4,886,616 | – | – |
|
17
Nurix Therapeutics
NRIX
$714M
| $16.2M | 2.02% | 1,822,883 | – | – |
|
18
Solid Biosciences
SLDB
$427M
| $14.8M | 1.85% | 3,130,422 | – | – |
|
|
TSVT
19
DELISTED
2seventy bio
TSVT
| $14.4M | 1.8% | 1,408,901 | – | – |
|
20
Rapid Micro Biosystems
RPID
$107M
| $11M | 1.38% | 8,434,560 | – | – |
|
|
TVRD
21
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $10.8M | 1.35% | 2,204,449 -491,581 | -18% | -$2.41M |
|
22
X4 Pharmaceuticals
XFOR
$84.2M
| $10.6M | 1.33% | 12,202,510 | – | – |
|
|
MRNS
23
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $9.87M | 1.23% | 1,431,058 | – | – |
|
24
Xilio Therapeutics
XLO
$36.3M
| $8.89M | 1.11% | 2,805,413 | – | – |
|
25
Atea Pharmaceuticals
AVIR
$267M
| $8.33M | 1.04% | 2,485,638 | – | – |
|